Grifols GRFS
NASDAQ GRFS
$7.50 -0.04 (-0.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Notes Payables (2013 - 2015)

Updated

Grifols' Notes Payables was -$73.96 million in the quarter ended Dec 31, 2015, compared with -$68.48 million a year earlier.

Analysis

Grifols (GRFS) Notes Payables (2013 - 2015) Analysis & Trends

As of Dec 31, 2015, Notes Payables at Grifols came in at -$74.95 million.

  • In earlier years, Notes Payables was -$68.48 million in the year ended Dec 31, 2014 and -$61.54 million in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Grifols 5.11 Bn 1.45 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -73.78 Mn
Dec 31, 2014 -66.64 Mn
Dec 31, 2013 -62.44 Mn
API Access

Grifols Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GRFS&period=max&api_key=YOUR_API_KEY